<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">34601116</PMID><DateCompleted><Year>2022</Year><Month>02</Month><Day>23</Day></DateCompleted><DateRevised><Year>2023</Year><Month>02</Month><Day>17</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1878-1810</ISSN><JournalIssue CitedMedium="Internet"><Volume>241</Volume><PubDate><Year>2022</Year><Month>Mar</Month></PubDate></JournalIssue><Title>Translational research : the journal of laboratory and clinical medicine</Title><ISOAbbreviation>Transl Res</ISOAbbreviation></Journal><ArticleTitle>Central nervous system outcomes of COVID-19.</ArticleTitle><Pagination><StartPage>41</StartPage><EndPage>51</EndPage><MedlinePgn>41-51</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.trsl.2021.09.002</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1931-5244(21)00244-9</ELocationID><Abstract><AbstractText>The worldwide pandemic caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has infected an estimated 200 million people with over 4 million deaths. Although COVID-19, the disease caused by the SARS-CoV-2 virus, is primarily a respiratory disease, an increasing number of neurologic symptoms have been reported. Some of these symptoms, such as loss of smell or taste, are mild and non-life threatening, while others, such as stroke or seizure, are more critical. Many of these symptoms remain long after the acute illness has passed, a phenomenon known as "long COVID" or postacute sequelae of SARS-CoV-2 infection (PASC). Neurological symptoms can be difficult to study due to the complexity of the central and peripheral nervous system. These neurologic symptoms can be difficult to identify and quantitate. This narrative review will describe approaches for assessing neurologic manifestations of COVID-19, with examples of the data they provide, as well as some directions for future research to aid in understanding the pathophysiology of COVID-19-related neurological implications.</AbstractText><CopyrightInformation>Copyright &#xa9; 2021 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Doyle</LastName><ForeName>Margaret F</ForeName><Initials>MF</Initials><AffiliationInfo><Affiliation>Department of Pathology and Laboratory Medicine, Larner College of Medicine, University of Vermont, Colchester, Vermont. Electronic address: Margaret.doyle@uvm.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 AG067457</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>09</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Transl Res</MedlineTA><NlmUniqueID>101280339</NlmUniqueID><ISSNLinking>1878-1810</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002490" MajorTopicYN="N">Central Nervous System</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName><QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>8</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>9</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>9</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>10</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>2</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>10</Month><Day>3</Day><Hour>20</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>9</Month><Day>30</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34601116</ArticleId><ArticleId IdType="pmc">PMC8482653</ArticleId><ArticleId IdType="doi">10.1016/j.trsl.2021.09.002</ArticleId><ArticleId IdType="pii">S1931-5244(21)00244-9</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Zhou P, Yang XL, Wang XG, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020;579:270&#x2013;273.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7095418</ArticleId><ArticleId IdType="pubmed">32015507</ArticleId></ArticleIdList></Reference><Reference><Citation>Nath A. Neurologic complications of coronavirus infections. Neurology. 2020;94:809&#x2013;810.</Citation><ArticleIdList><ArticleId IdType="pubmed">32229625</ArticleId></ArticleIdList></Reference><Reference><Citation>Almqvist J, Granberg T, Tzortzakakis A, et al. Neurological manifestations of coronavirus infections - a systematic review. Ann Clin Transl Neurol. 2020;7:2057&#x2013;2071.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7461163</ArticleId><ArticleId IdType="pubmed">32853453</ArticleId></ArticleIdList></Reference><Reference><Citation>Belvis R. Headaches during COVID-19: my clinical case and review of the literature. Headache. 2020;60:1422&#x2013;1426.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7273035</ArticleId><ArticleId IdType="pubmed">32413158</ArticleId></ArticleIdList></Reference><Reference><Citation>Bolay H, Gul A, Baykan B. COVID-19 is a real headache! Headache. 2020;60:1415&#x2013;1421.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7272895</ArticleId><ArticleId IdType="pubmed">32412101</ArticleId></ArticleIdList></Reference><Reference><Citation>Rahman J, Muralidharan A, Quazi SJ, Saleem H, Khan S. Neurological and psychological effects of coronavirus (COVID-19): an overview of the current era pandemic. Cureus. 2020;12:e8460.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7282368</ArticleId><ArticleId IdType="pubmed">32528783</ArticleId></ArticleIdList></Reference><Reference><Citation>Cooper KW, Brann DH, Farruggia MC, et al. COVID-19 and the chemical senses: supporting players take center stage. Neuron. 2020;107:219&#x2013;233.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7328585</ArticleId><ArticleId IdType="pubmed">32640192</ArticleId></ArticleIdList></Reference><Reference><Citation>Bilinska K, Butowt R. Anosmia in COVID-19: a bumpy road to establishing a cellular mechanism. ACS Chem Neurosci. 2020;11:2152&#x2013;2155.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7467568</ArticleId><ArticleId IdType="pubmed">32673476</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Sarraj S, Troakes C, Hanley B, et al. Invited review: the spectrum of neuropathology in COVID-19. Neuropathol Appl Neurobiol. 2021;47:3&#x2013;16.</Citation><ArticleIdList><ArticleId IdType="pubmed">32935873</ArticleId></ArticleIdList></Reference><Reference><Citation>Garg RK, Paliwal VK, Gupta A. Encephalopathy in patients with COVID-19: a review. J Med Virol. 2021;93:206&#x2013;222.</Citation><ArticleIdList><ArticleId IdType="pubmed">32558956</ArticleId></ArticleIdList></Reference><Reference><Citation>Nordvig AS, Fong KT, Willey JZ, et al. Potential neurologic manifestations of COVID-19. Neurol Clin Pract. 2021;11:e135&#x2013;ee46.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8032406</ArticleId><ArticleId IdType="pubmed">33842082</ArticleId></ArticleIdList></Reference><Reference><Citation>Chougar L, Shor N, Weiss N, et al. Retrospective observational study of brain MRI findings in patients with acute SARS-CoV-2 infection and neurologic manifestations. Radiology. 2020;297:E313&#x2013;EE23.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7370354</ArticleId><ArticleId IdType="pubmed">32677875</ArticleId></ArticleIdList></Reference><Reference><Citation>Merkler AE, Parikh NS, Mir S, et al. Risk of ischemic stroke in patients with coronavirus disease 2019 (COVID-19) vs patients with influenza. JAMA Neurol. 2020;77(11):1366&#x2013;1372. doi: 10.1001/jamaneurol.2020.2730.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2020.2730</ArticleId><ArticleId IdType="pmc">PMC7333175</ArticleId><ArticleId IdType="pubmed">32614385</ArticleId></ArticleIdList></Reference><Reference><Citation>Montalvan V, Lee J, Bueso T, De Toledo J, Rivas K. Neurological manifestations of COVID-19 and other coronavirus infections: a systematic review. Clin Neurol Neurosurg. 2020;194</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7227498</ArticleId><ArticleId IdType="pubmed">32422545</ArticleId></ArticleIdList></Reference><Reference><Citation>Agosti E, Giorgianni A, D'Amore F, Vinacci G, Balbi S, Locatelli D. Is Guillain-Barre syndrome triggered by SARS-CoV-2? Case report and literature review. Neurol Sci. 2021;42:607&#x2013;612.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7343406</ArticleId><ArticleId IdType="pubmed">32643136</ArticleId></ArticleIdList></Reference><Reference><Citation>Adamczyk-Sowa M, Niedziela N, Kubicka-Baczyk K, Wierzbicki K, Jaroszewicz J, Sowa P. Neurological symptoms as a clinical manifestation of coronavirus disease 2019: implications for internists. Pol Arch Intern Med. 2021;131:54&#x2013;62.</Citation><ArticleIdList><ArticleId IdType="pubmed">32820884</ArticleId></ArticleIdList></Reference><Reference><Citation>Collantes MEV, Espiritu AI, Sy MCC, Anlacan VMM, Jamora RDG. Neurological manifestations in COVID-19 infection: a systematic review and meta-analysis. Can J Neurol Sci. 2021;48:66&#x2013;76.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7492583</ArticleId><ArticleId IdType="pubmed">32665054</ArticleId></ArticleIdList></Reference><Reference><Citation>Garg RK. Spectrum of neurological manifestations in COVID-19: a review. Neurol India. 2020;68:560&#x2013;572.</Citation><ArticleIdList><ArticleId IdType="pubmed">32643664</ArticleId></ArticleIdList></Reference><Reference><Citation>Iroegbu JD, Ifenatuoha CW, Ijomone OM. Potential neurological impact of coronaviruses: implications for the novel SARS-CoV-2. Neurol Sci. 2020;41:1329&#x2013;1337.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7232928</ArticleId><ArticleId IdType="pubmed">32424503</ArticleId></ArticleIdList></Reference><Reference><Citation>Keyhanian K, Umeton RP, Mohit B, Davoudi V, Hajighasemi F, Ghasemi M. SARS-CoV-2 and nervous system: from pathogenesis to clinical manifestation. J Neuroimmunol. 2020;350</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7647896</ArticleId><ArticleId IdType="pubmed">33212316</ArticleId></ArticleIdList></Reference><Reference><Citation>Lahiri D, Mondal R, Deb S, et al. Neuroinvasive potential of a primary respiratory pathogen SARS- CoV2: summarizing the evidences. Diabetes Metab Syndr. 2020;14:1053&#x2013;1060.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7331527</ArticleId><ArticleId IdType="pubmed">32640417</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohammadi S, Moosaie F, Aarabi MH. Understanding the immunologic characteristics of neurologic manifestations of SARS-CoV-2 and potential immunological mechanisms. Mol Neurobiol. 2020;57:5263&#x2013;5275.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7458880</ArticleId><ArticleId IdType="pubmed">32869183</ArticleId></ArticleIdList></Reference><Reference><Citation>Orru G, Conversano C, Malloggi E, Francesconi F, Ciacchini R, Gemignani A. Neurological complications of COVID-19 and possible neuroinvasion pathways: a systematic review. Int J Environ Res Public Health. 2020;17 doi: 10.3390/ijerph17186688.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph17186688</ArticleId><ArticleId IdType="pmc">PMC7558767</ArticleId><ArticleId IdType="pubmed">32937949</ArticleId></ArticleIdList></Reference><Reference><Citation>Padda I, Khehra N, Jaferi U, Parmar MS. The Neurological complexities and prognosis of COVID-19. SN Compr Clin Med. 2020;(Sep 29):1&#x2013;12. doi: 10.1007/s42399-020-00527-2. In press.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s42399-020-00527-2</ArticleId><ArticleId IdType="pmc">PMC7522181</ArticleId><ArticleId IdType="pubmed">33015552</ArticleId></ArticleIdList></Reference><Reference><Citation>Pinzon RT, Wijaya VO, Buana RB, Al Jody A, Nunsio PN. Neurologic characteristics in coronavirus disease 2019 (COVID-19): a systematic review and meta-analysis. Front Neurol. 2020;11:565.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7273516</ArticleId><ArticleId IdType="pubmed">32574250</ArticleId></ArticleIdList></Reference><Reference><Citation>Pons-Escoda A, Naval-Baudin P, Majos C, et al. Neurologic involvement in COVID-19: cause or coincidence? A neuroimaging perspective. AJNR Am J Neuroradiol. 2020;41:1365&#x2013;1369.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7658883</ArticleId><ArticleId IdType="pubmed">32527842</ArticleId></ArticleIdList></Reference><Reference><Citation>Iadecola C, Anrather J, Kamel H. Effects of COVID-19 on the nervous system. Cell. 2020;183:16&#x2013;27. e1.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7437501</ArticleId><ArticleId IdType="pubmed">32882182</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Y, Xu X, Chen Z, et al. Nervous system involvement after infection with COVID-19 and other coronaviruses. Brain Behav Immun. 2020;87:18&#x2013;22.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7146689</ArticleId><ArticleId IdType="pubmed">32240762</ArticleId></ArticleIdList></Reference><Reference><Citation>Wada S, Nagasaki Y, Arimizu Y, et al. Neurological disorders identified during treatment of a SARS-CoV-2 infection. Intern Med. 2020;59:2187&#x2013;2189.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7516316</ArticleId><ArticleId IdType="pubmed">32713924</ArticleId></ArticleIdList></Reference><Reference><Citation>Palaiodimou L, Stefanou MI, Katsanos AH, et al. Prevalence, clinical characteristics and outcomes of Guillain-Barre syndrome spectrum associated with COVID-19: A systematic review and meta-analysis. Eur J Neurol. 2021;28:3517&#x2013;3529.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8250909</ArticleId><ArticleId IdType="pubmed">33837630</ArticleId></ArticleIdList></Reference><Reference><Citation>Affes Z, Bouvard EJ, Levy P, Dussaule C, Grateau G, Haymann JP. COVID-19 presenting with confusion: an unusual but suggestive electroencephalography pattern of encephalitis. J Clin Neurophysiol. 2021;38:e11&#x2013;ee3.</Citation><ArticleIdList><ArticleId IdType="pubmed">33149093</ArticleId></ArticleIdList></Reference><Reference><Citation>Faber I, Brandao PRP, Menegatti F, de Carvalho Bispo DD, Maluf FB, Cardoso F. Coronavirus disease 2019 and parkinsonism: a non-post-encephalitic case. Mov Disord. 2020;35:1721&#x2013;1722.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7461093</ArticleId><ArticleId IdType="pubmed">32815213</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen ME, Eichel R, Steiner-Birmanns B, et al. A case of probable Parkinson's disease after SARS-CoV-2 infection. Lancet Neurol. 2020;19:804&#x2013;805.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7494295</ArticleId><ArticleId IdType="pubmed">32949534</ArticleId></ArticleIdList></Reference><Reference><Citation>Mendez-Guerrero A, Laespada-Garcia MI, Gomez-Grande A, et al. Acute hypokinetic-rigid syndrome following SARS-CoV-2 infection. Neurology. 2020;95:e2109. e18.</Citation><ArticleIdList><ArticleId IdType="pubmed">32641525</ArticleId></ArticleIdList></Reference><Reference><Citation>Brundin P, Nath A, Beckham JD. Is COVID-19 a perfect storm for Parkinson's disease? Trends Neurosci. 2020;43:931&#x2013;933.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7577682</ArticleId><ArticleId IdType="pubmed">33158605</ArticleId></ArticleIdList></Reference><Reference><Citation>Asadi-Pooya AA, Simani L, Shahisavandi M, Barzegar Z. COVID-19, de novo seizures, and epilepsy: a systematic review. Neurol Sci. 2021;42:415&#x2013;431.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7686454</ArticleId><ArticleId IdType="pubmed">33237493</ArticleId></ArticleIdList></Reference><Reference><Citation>Bellocchio L, Bordea IR, Ballini A, et al. Environmental issues and neurological manifestations associated with COVID-19 pandemic: new aspects of the disease? Int J Environ Res Public Health. 2020;17</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7663018</ArticleId><ArticleId IdType="pubmed">33139595</ArticleId></ArticleIdList></Reference><Reference><Citation>Ellul MA, Benjamin L, Singh B, et al. Neurological associations of COVID-19. Lancet Neurol. 2020;19:767&#x2013;783.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7332267</ArticleId><ArticleId IdType="pubmed">32622375</ArticleId></ArticleIdList></Reference><Reference><Citation>Gane SB, Kelly C, Hopkins C. Isolated sudden onset anosmia in COVID-19 infection. A novel syndrome? Rhinology. 2020;58:299&#x2013;301.</Citation><ArticleIdList><ArticleId IdType="pubmed">32240279</ArticleId></ArticleIdList></Reference><Reference><Citation>Jardim Vaz de Mello L, Guimaraes Silva E, Oliveira Correa Rabelo G, et al. Neurologic compromise in COVID-19: a literature review. J Neurol Res. 2020;10:164&#x2013;172.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8040461</ArticleId><ArticleId IdType="pubmed">33984100</ArticleId></ArticleIdList></Reference><Reference><Citation>Jasti M, Nalleballe K, Dandu V, Onteddu S. A review of pathophysiology and neuropsychiatric manifestations of COVID-19. J Neurol. 2021;268:2007&#x2013;2012.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7268182</ArticleId><ArticleId IdType="pubmed">32494854</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuroda N. Epilepsy and COVID-19: updated evidence and narrative review. Epilepsy Behav. 2021;116</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7805398</ArticleId><ArticleId IdType="pubmed">33515934</ArticleId></ArticleIdList></Reference><Reference><Citation>Mondal R, Ganguly U, Deb S, et al. Meningoencephalitis associated with COVID-19: a systematic review. J Neurovirol. 2021;27:12&#x2013;25.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7765701</ArticleId><ArticleId IdType="pubmed">33367960</ArticleId></ArticleIdList></Reference><Reference><Citation>Severo Bem Junior L, do Rego Aquino PL, Nunes Rabelo N, et al. SARS-CoV-2 and nervous system - neurological manifestations in patients with COVID-19: a systematic review. J Neurol Res. 2020;10:113&#x2013;121.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8040459</ArticleId><ArticleId IdType="pubmed">33984094</ArticleId></ArticleIdList></Reference><Reference><Citation>Varatharaj A, Thomas N, Ellul MA, et al. Neurological and neuropsychiatric complications of COVID-19 in 153 patients: a UK-wide surveillance study. Lancet Psychiatry. 2020;7:875&#x2013;882.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7316461</ArticleId><ArticleId IdType="pubmed">32593341</ArticleId></ArticleIdList></Reference><Reference><Citation>Nasserie T, Hittle M, Goodman SN. Assessment of the frequency and variety of persistent symptoms among patients with COVID-19: a systematic review. JAMA Netw Open. 2021;4</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8155823</ArticleId><ArticleId IdType="pubmed">34037731</ArticleId></ArticleIdList></Reference><Reference><Citation>Lewis A, Frontera J, Placantonakis DG, et al. Cerebrospinal fluid in COVID-19: a systematic review of the literature. J Neurol Sci. 2021;421</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7833669</ArticleId><ArticleId IdType="pubmed">33561753</ArticleId></ArticleIdList></Reference><Reference><Citation>Mao L, Jin H, Wang M, et al. Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol. 2020;77:683&#x2013;690.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7149362</ArticleId><ArticleId IdType="pubmed">32275288</ArticleId></ArticleIdList></Reference><Reference><Citation>Rifino N, Censori B, Agazzi E, et al. Neurologic manifestations in 1760 COVID-19 patients admitted to Papa Giovanni XXIII Hospital, Bergamo, Italy. J Neurol. 2021;268:2331&#x2013;2338.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7539268</ArticleId><ArticleId IdType="pubmed">33026520</ArticleId></ArticleIdList></Reference><Reference><Citation>Garcia-Azorin D, Abildua MJA, Aguirre MEE, et al. Neurological presentations of COVID-19: findings from the Spanish Society of Neurology neuroCOVID-19 registry. J Neurol Sci. 2021;423</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7749644</ArticleId><ArticleId IdType="pubmed">33636661</ArticleId></ArticleIdList></Reference><Reference><Citation>Flores-Silva FD, Garcia-Grimshaw M, Valdes-Ferrer SI, et al. Neurologic manifestations in hospitalized patients with COVID-19 in Mexico City. PLoS One. 2021;16</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8031187</ArticleId><ArticleId IdType="pubmed">33831042</ArticleId></ArticleIdList></Reference><Reference><Citation>Frontera JA, Sabadia S, Lalchan R, et al. A prospective study of neurologic disorders in hospitalized patients with COVID-19 in New York City. Neurology. 2021;96:e575. e86.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7905791</ArticleId><ArticleId IdType="pubmed">33020166</ArticleId></ArticleIdList></Reference><Reference><Citation>Bain W, Yang H, Shah FA, et al. COVID-19 versus non-COVID-19 acute respiratory distress syndrome: comparison of demographics, physiologic parameters, inflammatory biomarkers, and clinical outcomes. Ann Am Thorac Soc. 2021;18:1202&#x2013;1210.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8328355</ArticleId><ArticleId IdType="pubmed">33544045</ArticleId></ArticleIdList></Reference><Reference><Citation>Fabbri VP, Foschini MP, Lazzarotto T, et al. Brain ischemic injury in COVID-19-infected patients: a series of 10 post-mortem cases. Brain Pathol. 2021;31:205&#x2013;210.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7536900</ArticleId><ArticleId IdType="pubmed">33002281</ArticleId></ArticleIdList></Reference><Reference><Citation>Solomon IH, Normandin E, Bhattacharyya S, et al. Neuropathological features of Covid-19. N Engl J Med. 2020;383:989&#x2013;992.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7304421</ArticleId><ArticleId IdType="pubmed">32530583</ArticleId></ArticleIdList></Reference><Reference><Citation>Meinhardt J, Radke J, Dittmayer C, et al. Olfactory transmucosal SARS-CoV-2 invasion as a port of central nervous system entry in individuals with COVID-19. Nat Neurosci. 2021;24:168&#x2013;175.</Citation><ArticleIdList><ArticleId IdType="pubmed">33257876</ArticleId></ArticleIdList></Reference><Reference><Citation>Matschke J, Lutgehetmann M, Hagel C, et al. Neuropathology of patients with COVID-19 in Germany: a post-mortem case series. Lancet Neurol. 2020;19:919&#x2013;929.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7535629</ArticleId><ArticleId IdType="pubmed">33031735</ArticleId></ArticleIdList></Reference><Reference><Citation>Chowdhary A, Subedi R, Tandon M, et al. Relevance and clinical significance of magnetic resonance imaging of neurological manifestations in COVID-19: a systematic review of case reports and case series. Brain Sci. 2020;10(12) doi: 10.3390/brainsci10121017.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/brainsci10121017</ArticleId><ArticleId IdType="pmc">PMC7766893</ArticleId><ArticleId IdType="pubmed">33371260</ArticleId></ArticleIdList></Reference><Reference><Citation>Egbert AR, Cankurtaran S, Karpiak S. Brain abnormalities in COVID-19 acute/subacute phase: a rapid systematic review. Brain Behav Immun. 2020;89:543&#x2013;554.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7366124</ArticleId><ArticleId IdType="pubmed">32682993</ArticleId></ArticleIdList></Reference><Reference><Citation>DeKosky ST, Kochanek PM, Valadka AB, et al. Blood biomarkers for detection of brain injury in COVID-19 patients. J Neurotrauma. 2021;38:1&#x2013;43.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7757533</ArticleId><ArticleId IdType="pubmed">33115334</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanberg N, Ashton NJ, Andersson LM, et al. Neurochemical evidence of astrocytic and neuronal injury commonly found in COVID-19. Neurology. 2020;95:e1754. e9.</Citation><ArticleIdList><ArticleId IdType="pubmed">32546655</ArticleId></ArticleIdList></Reference><Reference><Citation>De Lorenzo R, Lore NI, Finardi A, et al. Blood neurofilament light chain and total tau levels at admission predict death in COVID-19 patients. J Neurol. 2021 doi: 10.1007/s00415-021-10595-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-021-10595-6</ArticleId><ArticleId IdType="pmc">PMC8108733</ArticleId><ArticleId IdType="pubmed">33973106</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun B, Tang N, Peluso MJ, et al. Characterization and Biomarker Analyses of Post-COVID-19 Complications and Neurological Manifestations. Cells. 2021;10(2) doi: 10.3390/cells10020386.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells10020386</ArticleId><ArticleId IdType="pmc">PMC7918597</ArticleId><ArticleId IdType="pubmed">33668514</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazza MG, Palladini M, De Lorenzo R, et al. Persistent psychopathology and neurocognitive impairment in COVID-19 survivors: effect of inflammatory biomarkers at three-month follow-up. Brain Behav Immun. 2021;94:138&#x2013;147.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7903920</ArticleId><ArticleId IdType="pubmed">33639239</ArticleId></ArticleIdList></Reference><Reference><Citation>Proal AD, VanElzakker MB. Long COVID or post-acute sequelae of COVID-19 (PASC): an overview of biological factors that may contribute to persistent symptoms. Front Microbiol. 2021;12</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8260991</ArticleId><ArticleId IdType="pubmed">34248921</ArticleId></ArticleIdList></Reference><Reference><Citation>Soraas A, Bo R, Kalleberg KT, Stoer NC, Ellingjord-Dale M, Landro NI. Self-reported memory problems 8 months after COVID-19 infection. JAMA Netw Open. 2021;4</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8322992</ArticleId><ArticleId IdType="pubmed">34323987</ArticleId></ArticleIdList></Reference><Reference><Citation>Havervall S, Rosell A, Phillipson M, et al. Symptoms and functional impairment assessed 8 months after mild COVID-19 among health care workers. JAMA. 2021;325:2015&#x2013;2016.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8027932</ArticleId><ArticleId IdType="pubmed">33825846</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis HE, Assaf GS, McCorkell L, et al. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine. 2021;38</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>Elkan M, Dvir A, Zaidenstein R, et al. Patient-reported outcome measures after hospitalization during the COVID-19 pandemic: a survey among COVID-19 and non-COVID-19 patients. Int J Gen Med. 2021;14:4829&#x2013;4836.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8405220</ArticleId><ArticleId IdType="pubmed">34471377</ArticleId></ArticleIdList></Reference><Reference><Citation>Wanga V CJ, Dimitrov LV, et al. Long-term symptoms among adults tested for SARS-CoV-2 &#x2014; United States, January 2020&#x2013;April 2021. MMWR Morb Mortal Wkly Rep. 2021;70:1235&#x2013;1241.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8437054</ArticleId><ArticleId IdType="pubmed">34499626</ArticleId></ArticleIdList></Reference><Reference><Citation>Veenhuis RT, Zeiss CJ. Animal models of COVID-19 II. comparative immunology. ILAR J. 2021 doi: 10.1093/ilar/ilab010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ilar/ilab010</ArticleId><ArticleId IdType="pmc">PMC8135340</ArticleId><ArticleId IdType="pubmed">33914873</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeiss CJ, Compton S, Veenhuis RT. Animal Models of COVID-19. I. Comparative Virology and Disease Pathogenesis. ILAR J. 2021 doi: 10.1093/ilar/ilab007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ilar/ilab007</ArticleId><ArticleId IdType="pmc">PMC8083356</ArticleId><ArticleId IdType="pubmed">33836527</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng J, Wong LR, Li K, et al. COVID-19 treatments and pathogenesis including anosmia in K18-hACE2 mice. Nature. 2021;589:603&#x2013;607.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7855185</ArticleId><ArticleId IdType="pubmed">33166988</ArticleId></ArticleIdList></Reference><Reference><Citation>Bernard I, Limonta D, Mahal LK, Hobman TC. Endothelium infection and dysregulation by SARS-CoV-2: evidence and caveats in COVID-19. Viruses. 2020;13(1) doi: 10.3390/v13010029.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v13010029</ArticleId><ArticleId IdType="pmc">PMC7823949</ArticleId><ArticleId IdType="pubmed">33375371</ArticleId></ArticleIdList></Reference><Reference><Citation>Dittmayer C, Meinhardt J, Radbruch H, et al. Why misinterpretation of electron micrographs in SARS-CoV-2-infected tissue goes viral. Lancet. 2020;396:e64&#x2013;e65.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7535802</ArticleId><ArticleId IdType="pubmed">33031763</ArticleId></ArticleIdList></Reference><Reference><Citation>McCracken IR, Saginc G, He L, et al. Lack of evidence of angiotensin-converting enzyme 2 expression and replicative infection by SARS-CoV-2 in human endothelial cells. Circulation. 2021;143:865&#x2013;868.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7899720</ArticleId><ArticleId IdType="pubmed">33405941</ArticleId></ArticleIdList></Reference><Reference><Citation>Hui KPY, Cheung MC, Perera R, et al. Tropism, replication competence, and innate immune responses of the coronavirus SARS-CoV-2 in human respiratory tract and conjunctiva: an analysis in ex-vivo and in-vitro cultures. Lancet Respir Med. 2020;8:687&#x2013;695.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7252187</ArticleId><ArticleId IdType="pubmed">32386571</ArticleId></ArticleIdList></Reference><Reference><Citation>Roufosse C, Curtis E, Moran L, et al. Electron microscopic investigations in COVID-19: not all crowns are coronas. Kidney Int. 2020;98:505&#x2013;506.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7242192</ArticleId><ArticleId IdType="pubmed">32446936</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang L, Han Y, Nilsson-Payant BE, et al. A human pluripotent stem cell-based platform to study SARS-CoV-2 tropism and model virus infection in human cells and organoids. Cell Stem Cell. 2020;27:125&#x2013;136. e7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7303620</ArticleId><ArticleId IdType="pubmed">32579880</ArticleId></ArticleIdList></Reference><Reference><Citation>Schaefer IM, Padera RF, Solomon IH, et al. In situ detection of SARS-CoV-2 in lungs and airways of patients with COVID-19. Mod Pathol. 2020;33:2104&#x2013;2114.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7304376</ArticleId><ArticleId IdType="pubmed">32561849</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen J, Zhu YF, Du ZQ, et al. Predictors of mechanical ventilation for COVID-19: combined data from three designated hospitals. Eur Rev Med Pharmacol Sci. 2020;24:13065&#x2013;13071.</Citation><ArticleIdList><ArticleId IdType="pubmed">33378060</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang AC, Kern F, Losada PM, et al. Dysregulation of brain and choroid plexus cell types in severe COVID-19. Nature. 2021;595:565&#x2013;571.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8400927</ArticleId><ArticleId IdType="pubmed">34153974</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwabenland M, Salie H, Tanevski J, et al. Deep spatial profiling of human COVID-19 brains reveals neuroinflammation with distinct microanatomical microglia-T-cell interactions. Immunity. 2021;54:1594&#x2013;1610. e11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8188302</ArticleId><ArticleId IdType="pubmed">34174183</ArticleId></ArticleIdList></Reference><Reference><Citation>Buzhdygan TP, DeOre BJ, Baldwin-Leclair A, et al. The SARS-CoV-2 spike protein alters barrier function in 2D static and 3D microfluidic in-vitro models of the human blood-brain barrier. Neurobiol Dis. 2020;146</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7547916</ArticleId><ArticleId IdType="pubmed">33053430</ArticleId></ArticleIdList></Reference><Reference><Citation>Pezzini A, Grassi M, Silvestrelli G, et al. SARS-CoV-2 infection and acute ischemic stroke in Lombardy, Italy. J Neurol. 2021 doi: 10.1007/s00415-021-10620-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-021-10620-8</ArticleId><ArticleId IdType="pmc">PMC8142879</ArticleId><ArticleId IdType="pubmed">34031747</ArticleId></ArticleIdList></Reference><Reference><Citation>Blomberg B, Mohn KG, Brokstad KA, et al. Long COVID in a prospective cohort of home-isolated patients. Nat Med. 2021;27:1607&#x2013;1613.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8440190</ArticleId><ArticleId IdType="pubmed">34163090</ArticleId></ArticleIdList></Reference><Reference><Citation>Frontera JA, Yang D, Lewis A, et al. A prospective study of long-term outcomes among hospitalized COVID-19 patients with and without neurological complications. J Neurol Sci. 2021;426</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8113108</ArticleId><ArticleId IdType="pubmed">34000678</ArticleId></ArticleIdList></Reference><Reference><Citation>Graham EL, Clark JR, Orban ZS, et al. Persistent neurologic symptoms and cognitive dysfunction in non-hospitalized Covid-19 "long haulers". Ann Clin Transl Neurol. 2021;8:1073&#x2013;1085.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8108421</ArticleId><ArticleId IdType="pubmed">33755344</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M, Geddes JR, Husain M, Luciano S, Harrison PJ. 6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records. Lancet Psychiatry. 2021;8:416&#x2013;427.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8023694</ArticleId><ArticleId IdType="pubmed">33836148</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A, Sehgal K, Gupta A, et al. Post-acute COVID-19 syndrome. Nat Med. 2021;27:601&#x2013;615.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Sholzberg M, Tang GH, Rahhal H, et al. Heparin for Moderately Ill Patients with Covid-19. medRxiv. 2021 doi: 10.1101/2021.07.08.21259351. In press.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.07.08.21259351</ArticleId></ArticleIdList></Reference><Reference><Citation>Balcells ME, Rojas L, Le Corre N, et al. Early versus deferred anti-SARS-CoV-2 convalescent plasma in patients admitted for COVID-19: A randomized phase II clinical trial. PLoS Med. 2021;18</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7929568</ArticleId><ArticleId IdType="pubmed">33657114</ArticleId></ArticleIdList></Reference><Reference><Citation>Bennett-Guerrero E, Romeiser JL, Talbot LR, et al. Severe acute respiratory syndrome coronavirus 2 convalescent plasma versus standard plasma in coronavirus disease 2019 infected hospitalized patients in New York: a double-blind randomized trial. Crit Care Med. 2021;49:1015&#x2013;1025.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9658886</ArticleId><ArticleId IdType="pubmed">33870923</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamilton FW, Lee T, Arnold DT, Lilford R, Hemming K. Is convalescent plasma futile in COVID-19? A Bayesian re-analysis of the RECOVERY randomized controlled trial. Int J Infect Dis. 2021;109:114&#x2013;117.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8214317</ArticleId><ArticleId IdType="pubmed">34157385</ArticleId></ArticleIdList></Reference><Reference><Citation>Sarkar S, Soni KD, Khanna P. Convalescent plasma is a clutch at straws in COVID-19 management! A systematic review and meta-analysis. J Med Virol. 2021;93:1111&#x2013;1118.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7436491</ArticleId><ArticleId IdType="pubmed">32776573</ArticleId></ArticleIdList></Reference><Reference><Citation>Sekine L, Arns B, Fabro BR, et al. Convalescent plasma for COVID-19 in hospitalised patients: an open-label, randomised clinical trial. Eur Respir J. 2021 doi: 10.1183/13993003.01471-2021. In press.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.01471-2021</ArticleId><ArticleId IdType="pmc">PMC8287736</ArticleId><ArticleId IdType="pubmed">34244316</ArticleId></ArticleIdList></Reference><Reference><Citation>Oelsner EC, Allen NB, Ali T, et al. Collaborative cohort of cohorts for COVID-19 research (C4R) study: study design. medRxiv. 2021 doi: 10.1101/2021.03.19.21253986.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.03.19.21253986</ArticleId><ArticleId IdType="pmc">PMC8992336</ArticleId><ArticleId IdType="pubmed">35279711</ArticleId></ArticleIdList></Reference><Reference><Citation>Douaud G, Lee S, Alfaro-Almagro F, et al. Brain imaging before and after COVID-19 in UK Biobank. medRxiv. 2021 doi: 10.1101/2021.06.11.21258690.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.06.11.21258690</ArticleId></ArticleIdList></Reference><Reference><Citation>Bannister BA. Post-infectious disease syndrome. Postgrad Med J. 1988;64:559&#x2013;567.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2428896</ArticleId><ArticleId IdType="pubmed">3074289</ArticleId></ArticleIdList></Reference><Reference><Citation>Rebman AW, Aucott JN. Post-treatment Lyme disease as a model for persistent symptoms in Lyme disease. Front Med (Lausanne) 2020;7:57.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7052487</ArticleId><ArticleId IdType="pubmed">32161761</ArticleId></ArticleIdList></Reference><Reference><Citation>Lo TQ, Marston BJ, Dahl BA, De Cock KM. Ebola: anatomy of an epidemic. Annu Rev Med. 2017;68:359&#x2013;370.</Citation><ArticleIdList><ArticleId IdType="pubmed">27813879</ArticleId></ArticleIdList></Reference><Reference><Citation>Komaroff AL, Bateman L. Will COVID-19 lead to myalgic encephalomyelitis/chronic fatigue syndrome? Front Med (Lausanne) 2020;7</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7848220</ArticleId><ArticleId IdType="pubmed">33537329</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilson HW, Amo-Addae M, Kenu E, Ilesanmi OS, Ameme DK, Sackey SO. Post-Ebola syndrome among Ebola virus disease survivors in Montserrado County, Liberia 2016. Biomed Res Int. 2018;2018</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6046154</ArticleId><ArticleId IdType="pubmed">30050920</ArticleId></ArticleIdList></Reference><Reference><Citation>Keita AK, Vidal N, Toure A, et al. A 40-month follow-up of Ebola virus disease survivors in Guinea (PostEbogui) reveals long-term detection of Ebola viral ribonucleic acid in semen and breast milk. Open Forum Infect Dis. 2019;6:ofz482.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7047953</ArticleId><ArticleId IdType="pubmed">32128327</ArticleId></ArticleIdList></Reference><Reference><Citation>Halpin P, Williams MV, Klimas NG, Fletcher MA, Barnes Z, Ariza ME. Myalgic encephalomyelitis/chronic fatigue syndrome and gulf war illness patients exhibit increased humoral responses to the herpesviruses-encoded dUTPase: Implications in disease pathophysiology. J Med Virol. 2017;89:1636&#x2013;1645.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5513753</ArticleId><ArticleId IdType="pubmed">28303641</ArticleId></ArticleIdList></Reference><Reference><Citation>Chapenko S, Krumina A, Logina I, et al. Association of active human herpesvirus-6, -7 and parvovirus b19 infection with clinical outcomes in patients with myalgic encephalomyelitis/chronic fatigue syndrome. Adv Virol. 2012;2012</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3426163</ArticleId><ArticleId IdType="pubmed">22927850</ArticleId></ArticleIdList></Reference><Reference><Citation>Chia J, Chia A, Voeller M, Lee T, Chang R. Acute enterovirus infection followed by myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and viral persistence. J Clin Pathol. 2010;63:165&#x2013;168.</Citation><ArticleIdList><ArticleId IdType="pubmed">19828908</ArticleId></ArticleIdList></Reference><Reference><Citation>Bastard P, Rosen LB, Zhang Q, et al. Autoantibodies against type I IFNs in patients with life-threatening COVID-19. Science. 2020;370(6515) doi: 10.1126/science.abd4585.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abd4585</ArticleId><ArticleId IdType="pmc">PMC7857397</ArticleId><ArticleId IdType="pubmed">32972996</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumata R, Ito J, Takahashi K, Suzuki T, Sato K. A tissue level atlas of the healthy human virome. BMC Biol. 2020;18:55.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7269688</ArticleId><ArticleId IdType="pubmed">32493363</ArticleId></ArticleIdList></Reference><Reference><Citation>NIH Recover announcement. September 15, 2021. NIH builds large nationwide study population of tens of thousands to support research on long-term effects of COVID-19. https://www.nih.gov/news-events/news-releases/nih-builds-large-nationwide-study-population-tens-thousands-support-research-long-term-effects-covid-19.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>